Similar articles

• Significance of neurotransmitter abnormalities in Alzheimer's disease.

  Katzman R, Brown T, Fuld P, Thal L, Davies P, Terry R. Katzman R, et al. Res Publ Assoc Res Nerv Ment Dis. 1986;64:279-86. Res Publ Assoc Res Nerv Ment Dis. 1986. PMID: 2873637 No abstract available.
• Peptide-containing neurons of the primate cerebral cortex.

  Jones EG, Hendry SH. Jones EG, et al. Res Publ Assoc Res Nerv Ment Dis. 1986;64:163-78. Res Publ Assoc Res Nerv Ment Dis. 1986. PMID: 2425404 Review. No abstract available.
• Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.

  Bird TD, Stranahan S, Sumi SM, Raskind M. Bird TD, et al. Ann Neurol. 1983 Sep;14(3):284-93. doi: 10.1002/ana.410140306. Ann Neurol. 1983. PMID: 6227276
• Disease-related protein changes in purified neurons from Alzheimer's and Huntington's diseases.

  Selkoe DJ. Selkoe DJ. Trans Am Neurol Assoc. 1979;104:70-4. Trans Am Neurol Assoc. 1979. PMID: 162259 No abstract available.
• Putative peptide neurotransmitters in human neuropathology: a review of topography and clinical implications.

  Constantinidis J, Bouras C, Richard J. Constantinidis J, et al. Clin Neuropathol. 1983;2(2):47-54. Clin Neuropathol. 1983. PMID: 6189657 Review.